
Latest Health News
Germany Allocates €500 Million for Long COVID and Post-Infection Syndrome Research
The German government committed half a billion euros to a National Decade Against Post-Infectious Diseases (2026-2036), accelerating long COVID and chronic fatigue syndrome research. This investment aims to find new treatments amid increasing health burdens, with long COVID affecting millions and costing the global economy about $1 trillion annually.
Significant Advances in Personalized Cancer Treatments and Gene Editing
2025 saw major strides in personalized cancer therapies, including FDA-approved drug combinations for rare ovarian cancers and gene-edited CAR-T cells for aggressive leukemia. CRISPR was notably used to treat a rare metabolic disorder in an infant, demonstrating the potential of tailored genetic therapies.
FDA Approves New HIV PrEP Injectable and Novel Malaria Antibody Treatments
A new two-year injectable HIV pre-exposure prophylaxis, Yeztugo (lenacapavir), was approved showing near 100% prevention efficacy. Additionally, a novel class of malaria antibodies targeting stable parasite structures emerged as promising candidates for durable vaccines.
First Fully Robotic Lymphatic Microsurgery Performed in the U.S.
Dr. Nicholas J. Panetta at USF Health and Tampa General Hospital performed the first fully robotic lymphovenous bypass using FDA-cleared NanoWrist Dissection Instruments and the Symani Surgical System. This breakthrough offers unprecedented precision and minimally invasive care for lymphedema patients.
PAHO Calls for Strengthened Public Health Investment in the Americas to Achieve Universal Health
On Universal Health Day, PAHO urged countries in the Americas to boost health financing and strengthen primary care to reduce out-of-pocket expenses and health inequities, emphasizing financial protection as critical for universal health coverage.